Results 141 to 150 of about 33,822 (221)

Respiratory microbiota dynamics in piglets under nanotechnology-based and conventional vaccination protocols against Mycoplasma hyopneumoniae. [PDF]

BMC Vet Res
de Oliveira LG, Lopes Mechler-Dreibi M, Storino GY, Moreira Petri FA, Carvalho Abreu Fantini M, Silva Martins T.   +5 more
europepmc   +1 more source

<i>Mycoplasma hyopneumoniae</i> modulates ciliary function and epithelial integrity in air-liquid interface porcine respiratory epithelial cells (ALI-PRECs). [PDF]

Microbiol Spectr
Castillo-Espinoza AF, Nelli RK, Mora-Díaz JC, Zhang D, Rauh R, Reddi BM, Saxena A, Twu N-C, Espin-Palazón R, Giménez-Lirola LG.   +9 more
europepmc   +1 more source

A genetic and virulence characterization of Brazilian strains of Mycoplasma hyopneumoniae. [PDF]

Front Microbiol, 2023
Toledo LT, de Souza LFL, Pereira CER, Polveiro RC, Bressan GC, Yamatogi RS, Jeong KC, Marks FS, Diamantino CA, de Carvalho VHR, Malcher CS, Petri FAM, de Oliveira LG, Moreira MAS, Silva-Júnior A.   +14 more
europepmc   +1 more source

Mycoplasma hyopneumoniae prevalence at weaning: What do we know (and do not know) about it?

, 2012
Pieters, Maria. (2012). Mycoplasma hyopneumoniae prevalence at weaning: What do we know (and do not know) about it?.
Pieters, Maria
core  

Integrated transcriptome and metabolome reveal <i>Mycoplasma hyopneumoniae</i> -induced lipid accumulation, inflammation, oxidative stress, and energy imbalance in the liver of pigs. [PDF]

Virulence
Xue X, Bu Y, Yu C, Li J, Yang J, Gao M, Wang P, Gan Y, Zhang W, Fan S, Zhou R, Yin Z, Zheng X.   +12 more
europepmc   +1 more source

Comparative Safety and Efficacy of Commercial Porcine Vaccines Against <i>Mycoplasma hyopneumoniae</i> and Porcine Circovirus Type 2 (PCV2). [PDF]

Animals (Basel)
Simon-Grifé M, Moros A, Pedernera C, Puigvert E, Acal L, Plantalech E, Roca M, Montané J, March R, Sitjà M.   +9 more
europepmc   +1 more source

Efficacy of a new ready-to-use PCV2 and <i>Mycoplasma hyopneumoniae</i> vaccine under field conditions. [PDF]

Vet Med (Praha)
Trampus P, Csagola A, Szalai T, Palmai N, Toth A, Terenyi N, Nagy Z, Szeplaki NA, Somogyi G, Rausch E, Penzes Z, Krejci R.   +11 more
europepmc   +1 more source

Efficacy of genetically modified Mycoplasma hyopneumoniae strains and their effect on local and cell-mediated immune responses in pigs. [PDF]

Vet Res
Beuckelaere L, Boyen F, Auray G, Haspeslagh M, De Coensel E, Trueeb BS, Meyer E, Haesebrouck F, De Spiegelaere W, Devriendt B, Summerfield A, Kuhnert P, Maes D.   +12 more
europepmc   +1 more source

Prevalence and Risk Factors of Mycoplasma Hyopneumoniae in Swine Farms, Mainland China, 2003-2024: A Meta-Analysis. [PDF]

Vet Sci
Zhou H, Zhang H, Zhang X, Ye L, Liu X, Zhang T.   +5 more
europepmc   +1 more source

Comparative Codon Usage Bias of CD2AP and BACH2 Across 49 Vertebrates: Implications for Porcine Macrophage Immunity in <i>Mycoplasma hyopneumoniae</i> Infection. [PDF]

Biology (Basel)
Li W, Wang P, Liu J, Xue X, Fan S, Ding Y, Zhang X, Yin Z, Zheng X.   +8 more
europepmc   +1 more source